Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
United Therapeutic
(NQ:
UTHR
)
376.80
+2.78 (+0.74%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 4, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about United Therapeutic
< Previous
1
2
3
4
5
6
7
8
9
Next >
7 Under-the-Radar Biotech Stocks Gearing Up for Liftoff
February 26, 2024
Although the health innovation space can be a risky environment, undervalued biotech stocks can take some of the edge off.
Via
InvestorPlace
Beyond The Numbers: 4 Analysts Discuss United Therapeutics Stock
February 22, 2024
Via
Benzinga
United Therapeutics' Challenges FDA Over Liquidia's Drug Approval Process, Clocks Strong Q4 Earnings
February 21, 2024
Legal battle unfolds as United Therapeutics challenges FDA's handling of Liquidia's drug approval process. Explore the implications on PH-ILD, potential 30-month stay, and recent financial...
Via
Benzinga
Exposures
Product Safety
United Therapeutics Corporation Reports Fourth Quarter and Full Year 2023 Financial Results
February 21, 2024
From
United Therapeutics Corporation
Via
Business Wire
United Therapeutics Commences Litigation to Ensure Fairness in the Drug Review Process
February 21, 2024
From
United Therapeutics Corporation
Via
Business Wire
Earnings Scheduled For February 21, 2024
February 21, 2024
Companies Reporting Before The Bell • Gatos Silver (NYSE:GATO) is estimated to report quarterly earnings at $0.09 per share on revenue of $83.00 million.
Via
Benzinga
Earnings Outlook For United Therapeutics
February 20, 2024
Via
Benzinga
This United Therapeutics Analyst Is No Longer Bearish, Expects Mid-Decade $4B Revenue Run Rate
February 12, 2024
United Therapeutics Corporation (NASDAQ: UTHR) is in a patent dispute with Liquidia Corp (NASDAQ:
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
Teva Pharmaceutical To Rally Around 58%? Here Are 10 Top Analyst Forecasts For Monday
February 12, 2024
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via
Benzinga
Biotech Stocks Are on Fire: Here Are the Top 3 Picks for January
January 25, 2024
These biotech stocks offer exciting and disruptive solutions with the potential to expand to market caps worth trillions.
Via
InvestorPlace
Catalyst Countdown: 3 Biotech Stocks With Upcoming News That Could Move the Market
January 16, 2024
In the volatile world of biotech stocks, keeping an eye on the news is critical. Here are three companies to look out for.
Via
InvestorPlace
United Therapeutics Corporation to Present at the 42nd Annual J.P. Morgan Healthcare Conference
December 29, 2023
From
United Therapeutics Corporation
Via
Business Wire
Liquidia: Court victory the awakening of an industry giant?
December 27, 2023
Liquidia's stock surged after an enormous court win against United Therapeutics, accompanied by analyst upgrades and insider buying.
Via
MarketBeat
Topics
Intellectual Property
Exposures
Intellectual Property
Why Is Pulmonary Hypertension-Focused Liquidia Stock Soaring Today?
December 20, 2023
Liquidia Corp (NASDAQ: LQDA) stock jumped after a win in a pat
Via
Benzinga
United Therapeutics and Miromatrix Medical Announce Completion of Tender Offer and Merger
December 13, 2023
From
United Therapeutics Corporation
Via
Business Wire
United Therapeutics and Miromatrix Medical Announce Successful Tender Offer
December 12, 2023
From
United Therapeutics Corporation
Via
Business Wire
United Therapeutics Named by Newsweek as One of America’s Most Responsible Companies 2024
December 07, 2023
From
United Therapeutics Corporation
Via
Business Wire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Eargo, Inc. (Nasdaq – EAR), Miromatrix Medical, Inc. (Nasdaq – MIRO), Physicians Realty Trust (NYSE – DOC), Spirit Realty Capital (NYSE – SRC)
November 13, 2023
From
Brodsky & Smith LLC
Via
GlobeNewswire
7 Healthcare Stocks That Are Poised to Become the Next Unicorns
November 09, 2023
Discover healthcare stocks with remarkable potential for growth and "unicorn" status in the ever-evolving world of healthcare investments.
Via
InvestorPlace
Flying Car Stocks: What a Devastating Short Report Means for EHang
November 08, 2023
Hindenburg raised red flags for flying car stocks after releasing a short report on EH stock. Here's what investors should watch.
Via
InvestorPlace
EH Stock Alert: Hindenburg Slams EHang in New Short Report
November 07, 2023
EH stock is falling back to earth after Hindenburg Research issued a short report on the electric vertical take-off and landing (eVTOL) firm.
Via
InvestorPlace
United Therapeutics Corporation Reports Third Quarter 2023 Financial Results
November 01, 2023
From
United Therapeutics Corporation
Via
Business Wire
United Therapeutics Announces First Patient Enrolled in Phase 3 TETON PPF Study of Nebulized Tyvaso in Patients with Progressive Pulmonary Fibrosis
October 31, 2023
From
United Therapeutics Corporation
Via
Business Wire
Earnings Scheduled For November 1, 2023
November 01, 2023
Companies Reporting Before The Bell • GSK (NYSE:GSK) is expected to report quarterly earnings at $1.07 per share on revenue of $9.37 billion.
Via
Benzinga
United Therapeutics Corporation to Present at the UBS Biopharma Conference 2023
October 31, 2023
From
United Therapeutics Corporation
Via
Business Wire
Health Care Company United Therapeutics Announces Acquisition of Miromatrix Medical
October 30, 2023
Via
Benzinga
Why Is Life Sciences Company Miromatrix Medical Stock Trading Higher Today?
October 30, 2023
United Therapeutics Corporation (NASDAQ: UTHR) has agreed to acquire Miromatrix Medical Inc (NASDAQ: MIRO) for $3.25 per share in cash (an aggregate of approximately $91 million).
Via
Benzinga
Why Is Miromatrix Medical (MIRO) Stock Up 235% Today?
October 30, 2023
Miromatrix Medical stock is rocketing higher on Monday after the company reached an acquisition agreement with United Therapeutics for MIRO.
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
October 30, 2023
It's time to dive into the biggest pre-market stock movers as we start the trading week on Monday with the hottest coverage!
Via
InvestorPlace
United Therapeutics to Acquire Miromatrix Medical
October 30, 2023
From
Miromatrix Medical Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.